Skip to content
Contact Us
0
IDKmonitor Infliximab drug level assay
Back To Our Shop

Infliximab Drug Level ELISA (IDKmonitor®)

Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Infliximab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free infliximab in plasma or serum samples.

Category:

Key Advantages

Highly specific quantification of infliximab, with no cross reaction with adalimumab, golimumab and other plasma proteins

Total incubation time 130 minutes

Saves costs by predicting efficacy of infliximab treatment and stratifying patients accordingly

Applicable to both gastroenterology and rheumatology

Reportable range 0.53-45 ug/ml

Automatable on ELISA automates (e.g. Dynex DS2)

Determination of free therapeutic infliximab

Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Infliximab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free infliximab in plasma or serum samples. Not all patients respond equally to infliximab, and this test helps to stratify patients according to whether they are likely to benefit from treatment or not, allowing clinicians to evaluate the drug efficacy and investigate primary non-response and loss of response.

​​​​The assay is widely available throughout the UK and Ireland to both routine clinical laboratories as well as for research applications. Please contact us for your nearest test reference laboratory. This kit is supported by UK publications and evidence base.

  • ELISA

  • 40 tests

  • Storage: 2-8 °C

  • Blood sample